UK Regulator Will Scrutinize AstraZeneca-Alexion Deal
The United Kingdom's Competition and Markets Authority announced Tuesday that it's investigating a planned $39 billion merger between Swedish-British coronavirus vaccine producer AstraZeneca and U.S. drugmaker Alexion Pharmaceuticals Inc....To view the full article, register now.
Already a subscriber? Click here to view full article